Oral antigen exposure under costimulation blockade induces Treg cells to establish immune tolerance
Journal of Experimental Medicine · 2026
DOI: 10.1084/jem.20251635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Masaya Arai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Immunology, Immunology Frontier Research Center, The University of Osaka, Osaka, Japan. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Immune Tolerance, Antigens. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Nipponham Foundation for the Future of Food, Leading Advanced Projects for Medical Innovation.
Abstract (Originalsprache)
Antigen-specific oral tolerance prevents harmful immune responses in naïve animals but is difficult to induce in antigen-primed hosts. Here, we showed that feeding of antigen-containing diet generated peripherally derived regulatory T (pTreg) cells with tissue-adapted effector properties. They acquired Treg-specific epigenomic changes at Treg signature genes, including Foxp3, exhibiting stable suppressive function. Cessation of antigen feeding diminished pTreg cells, hampering tolerance induction. Notably, pTreg cells induced by antigen feeding predominantly expressed CD101. CD101+ Treg cells with similar phenotypic and epigenetic features could also be generated in vitro from antigen-primed naïve CD4+ T cells by blocking CD28-mediated costimulation during TGF-β–dependent Treg induction. Furthermore, in mice already antigen-sensitized by nonoral routes, in vivo blockade of CD28 signaling with CTLA4-Ig prior to antigen feeding promoted differentiation of antigen-specific T cells into CD101+ pTreg cells, facilitating oral tolerance. Thus, continuous oral antigen exposure combined with CD28 blockade generates functionally stable CD101+ pTreg cells, thereby establishing systemic antigen-specific tolerance even in antigen-presensitized hosts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Experimental Immunology, Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.
- Department of Experimental Immunology, Institute for Life and Medical Sciences, Kyoto University, Sakyo-ku, Japan.
- Genome Information Research Center, Research Institute for Microbial Diseases, The University of Osaka , Osaka, Japan.
- Department of Frontier Research in Tumor Immunology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
ORCID-Profile: Masaya Arai, Ryoji Kawakami, Yamami Nakamura, Yoko Naito, Daisuke Motooka, Atsushi Sugimoto, Tomiko Kimoto, Naganari Ohkura, Norihisa Mikami, Shimon Sakaguchi
Förderung
- Japan Society for the Promotion of Science
- Nipponham Foundation for the Future of Food
- Leading Advanced Projects for Medical Innovation
- Kyoto University
Zitieren
APA
Arai, M., Kawakami, R., Nakamura, Y., Naito, Y., Motooka, D., Sugimoto, A., Kimoto, T., Ohkura, N., Mikami, N., & Sakaguchi, S. (2026). Oral antigen exposure under costimulation blockade induces Treg cells to establish immune tolerance. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20251635
Vancouver
Arai M, Kawakami R, Nakamura Y, Naito Y, Motooka D, Sugimoto A, et al. Oral antigen exposure under costimulation blockade induces Treg cells to establish immune tolerance. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20251635
BibTeX
@article{Arai2026,
author = {Arai, Masaya and Kawakami, Ryoji and Nakamura, Yamami and Naito, Yoko and Motooka, Daisuke and Sugimoto, Atsushi and Kimoto, Tomiko and Ohkura, Naganari and Mikami, Norihisa and Sakaguchi, Shimon},
title = {Oral antigen exposure under costimulation blockade induces Treg cells to establish immune tolerance},
journal = {Journal of Experimental Medicine},
year = {2026},
doi = {10.1084/jem.20251635}
}
EUVIMED